Logo-jcvtr

J Cardiovasc Thorac Res. 2023;15(3): 138-144. doi: 10.34172/jcvtr.2023.31724
PMID: 38028722        PMCID: PMC10590461

Original Article

Sevoflurane-mediated modulation of oxidative myocardial injury

Siavash Sedghi 1,2 ORCID, Wiam Z. Khadra 1,2, Leili Pourafkari 1,3 ORCID, Paul R. Knight 1 ORCID, Faraz A. Alderson 4 ORCID, Nader D. Nader 1,2 * ORCID

Cited by CrossRef:

1- Chang Y, Zhang X, Zhang S, Qu G. Blood-brain barrier-penetrating Angiopep-2/Sirtuin 1 nanoparticles rescue sevoflurane neurotoxicity through multi-omics identified necroptosis pathways. J Nanobiotechnol. 2025;23(1) [Crossref]
2- Shi J, Hou S, Yao X. MiR-1291 mediates the protective effect of sevoflurane preconditioning against hypoxia/reoxygenation-induced myocardial cell injury. 2025;14(4) [Crossref]
3- Shao Y, Gu Q, Yuan Y, Wang L, Yu T. The Preconditioning with Sevoflurane Alleviates Hypoxia-Reoxygenation-Induced Myocardial Cell Injury by Regulating the lncRNA LINC00265/miR-370-3p Axis. Cardiovasc Toxicol. 2025;25(5):778 [Crossref]
4- Uryash A, Mijares A, Eltit J, Adams J, Lopez J. Cardioprotective effects of naringin in a type 2 diabetes rodent model by reducing calcium overload and oxidative stress. Front Pharmacol. 2025;16 [Crossref]
5- Lin J, Li X, Yang Y, Ge Z, Liu D, Yang C, Zhang L, Xia Z, Xia Z. Protective effects of sevoflurane conditioning against myocardial ischemia-reperfusion injury: a review of evidence from animal and clinical studies. Anesthesiol Perioper Sci. 2025;3(1) [Crossref]
6- Wang L, Zhu C, Shao Y, Chen R, Liang H. Sevoflurane reduces cardiomyocyte injury in a hypoxia/reoxygenation model of cardiomyocytes through the linc01278/miR-134-5pt regulatory axis. BMC Pharmacol Toxicol. 2025;26(1) [Crossref]